James F. Emigh, VP Marketing & Administration at ACURA PHARMACEUTICALS, INC (ACUR), bought 5,000 shares at $2.60 ($13K) on 2011-08-12, disclosed to the SEC on 2011-08-15.
Open-market purchase of $13k ACUR by VP Marketing & Administration. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.56 | 100 | $256 | 2.0% |
| 2 | $2.58 | 986 | $3K | 19.5% |
| 3 | $2.59 | 300 | $777 | 6.0% |
| 4 | $2.60 | 2,200 | $6K | 44.0% |
| 5 | $2.61 | 300 | $783 | 6.0% |
| 6 | $2.62 | 400 |
| $1K |
| 8.1% |
| 7 | $2.64 | 714 | $2K | 14.5% |
| Total | $2.60 avg | 5,000 | $13K | 100% |
| Filing → |